share_log

Investors Shouldn't Be Too Comfortable With Bruker's (NASDAQ:BRKR) Earnings

Investors Shouldn't Be Too Comfortable With Bruker's (NASDAQ:BRKR) Earnings

投資者不應該對布魯克(納斯達克股票代碼:BRKR)的收益過於滿意
Simply Wall St ·  05/21 07:15

Last week's profit announcement from Bruker Corporation (NASDAQ:BRKR) was underwhelming for investors, despite headline numbers being robust. We did some digging and found some worrying underlying problems.

儘管總體數據強勁,但布魯克公司(納斯達克股票代碼:BRKR)上週的盈利公告令投資者難以置信。我們進行了一些挖掘,發現了一些令人擔憂的潛在問題。

earnings-and-revenue-history
NasdaqGS:BRKR Earnings and Revenue History May 21st 2024
NASDAQGS: BRKR 收益和收入歷史記錄 2024 年 5 月 21 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Bruker's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from US$82m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. If Bruker doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

對於任何想了解布魯克在法定數字之外的利潤的人來說,值得注意的是,在過去的十二個月中,從價值8200萬美元的不尋常物品中獲得了法定利潤。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。當我們計算數千家上市公司的數字時,我們發現,特定年份中不尋常的項目所帶來的提振通常不會在第二年重演。這正如你所預料的那樣,因爲這些增強被描述爲 “不尋常”。如果布魯克認爲這種捐款不會重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Bruker's Profit Performance

我們對布魯克利潤表現的看法

Arguably, Bruker's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Bruker's statutory profits are better than its underlying earnings power. But the good news is that its EPS growth over the last three years has been very impressive. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Bruker, you'd also look into what risks it is currently facing. Case in point: We've spotted 2 warning signs for Bruker you should be aware of.

可以說,布魯克的法定收益被提高利潤的不尋常項目所扭曲。因此,我們認爲布魯克的法定利潤可能好於其基礎盈利能力。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。如果你想更深入地了解布魯克,你還需要研究它目前面臨的風險。一個很好的例子:我們發現了布魯克的兩個警告信號,你應該注意了。

This note has only looked at a single factor that sheds light on the nature of Bruker's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

本報告僅研究了揭示布魯克利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份擁有高股本回報率的公司的免費集合,或者這份內部所有權高的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論